Visual Outcomes and Patient Satisfaction After Implantation of Multifocal Sulcus IOL

Sunday, April 27, 2014: 8:51 AM
Room 150 (Boston Convention and Exhibition Center)
Victor A. Antunes, MD, Instituto de Oftalmologia de Assis, Assis, Brazil
Eduardo Andreghetti, MD, Inst. de Oftalmologia de Assis, Assis, Brazil

Narrative Responses:

Purpose
To assess visual outcomes and patient satisfaction following implantation of a multifocal sulcus intraocular lens (IOL) in a single surgical procedure combining primary capsular bag lens implantation.

Methods
The study included cataract patients older than 45 years of age, with hyperopia ≥1.50D and potential acuity measurement ≥20/30, undergoing Sulcoflex Supplementary multifocal IOL (Rayner IOLs) implantation in a single session combined with primary capsular bag IOL implantation. Eighty-six percent of eyes received an aspherical distance primary IOL, whereas the remaining received toric distance IOLs. All eyes received a plano multifocal Sulcoflex lens with +3.5D addition. Near and distance monocular and binocular visual acuity, refraction, and intraocular pressure (IOP) were measured 1 week, and 1 , 3, 6, and 9 months after surgery. Patient satisfaction was assessed 1 month post-operation.

Results
The study included 119 eyes (61 patients). 69% of eyes had pre-existing retinal pathologies. At 1-month, 81% of eyes had monocular UDVA 20/25 or better and 91% had monocular UNVA J2 or better. 96% and 93% of eyes, respectively had binocular UDVA 20/25 or better and binocular UNVA J2 or better. At 3-months, 88% and 51% of eyes, respectively, had spherical and cylindrical refraction within ±0.5D. The majority of patients reported satisfaction and improvements in quality of life. Complications included post-op IOP increase (19 eyes), anterior capsule rupture due to toric IOL rotation (1 eye), and Sulcoflex explantation (4 eyes).

Conclusion
Implantation of the multifocal Sulcoflex IOL improves near and distance visual acuity in cataract patients. Patients with retinal abnormalities were able to tolerate the multifocal IOL. The secondary IOL implantation is reversible and safe.